Selpercatinib in Early-Stage RET Fusion-Positive Non-Small-Cell Lung Cancer.
Saved in:
| Title: | Selpercatinib in Early-Stage RET Fusion-Positive Non-Small-Cell Lung Cancer. |
|---|---|
| Authors: | Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China., Hochmair M; Karl Landsteiner Institute for Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Vienna., Yang Y; Department of Thoracic Surgery, Affiliated Hospital of Southwest Jiaotong University, College of Medicine, Southwest Jiaotong University, Third People's Hospital of Chengdu, Chengdu, China., Yang XN; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China., Tsuboi M; National Cancer Center Hospital East, Kashiwa, Japan., Paz-Ares L; Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid., Yang JC; National Taiwan University Hospital, NTU Cancer Center, Taipei., Wu L; Hunan Cancer Hospital, Changsha, China., Kim HR; Division of Medical Oncology, Department of Internal Medicine, Yonsei University Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Rieke DT; Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin., Johnson M; Sarah Cannon Research Institute, Nashville., Besse B; Paris Saclay University, Gustave Roussy, Villejuif, France., Sharma N; Lilly, Indianapolis., Maeda P; Lilly, Indianapolis., Peterson P; Lilly, Indianapolis., Lin BK; Lilly, Indianapolis., Frimodt-Moller B; Lilly, Copenhagen., Goldman J; University of California, Los Angeles, Los Angeles., Drilon A; Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York. |
| Corporate Authors: | LIBRETTO-432 Trial Investigators |
| Source: | The New England journal of medicine [N Engl J Med] 2026 May 31. Date of Electronic Publication: 2026 May 31. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42223087 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Selpercatinib in Early-Stage RET Fusion-Positive Non-Small-Cell Lung Cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wu+YL%22">Wu YL</searchLink>; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Hochmair+M%22">Hochmair M</searchLink>; Karl Landsteiner Institute for Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Vienna.<br /><searchLink fieldCode="AU" term="%22Yang+Y%22">Yang Y</searchLink>; Department of Thoracic Surgery, Affiliated Hospital of Southwest Jiaotong University, College of Medicine, Southwest Jiaotong University, Third People's Hospital of Chengdu, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Yang+XN%22">Yang XN</searchLink>; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Tsuboi+M%22">Tsuboi M</searchLink>; National Cancer Center Hospital East, Kashiwa, Japan.<br /><searchLink fieldCode="AU" term="%22Paz-Ares+L%22">Paz-Ares L</searchLink>; Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid.<br /><searchLink fieldCode="AU" term="%22Yang+JC%22">Yang JC</searchLink>; National Taiwan University Hospital, NTU Cancer Center, Taipei.<br /><searchLink fieldCode="AU" term="%22Wu+L%22">Wu L</searchLink>; Hunan Cancer Hospital, Changsha, China.<br /><searchLink fieldCode="AU" term="%22Kim+HR%22">Kim HR</searchLink>; Division of Medical Oncology, Department of Internal Medicine, Yonsei University Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Rieke+DT%22">Rieke DT</searchLink>; Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin.<br /><searchLink fieldCode="AU" term="%22Johnson+M%22">Johnson M</searchLink>; Sarah Cannon Research Institute, Nashville.<br /><searchLink fieldCode="AU" term="%22Besse+B%22">Besse B</searchLink>; Paris Saclay University, Gustave Roussy, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Sharma+N%22">Sharma N</searchLink>; Lilly, Indianapolis.<br /><searchLink fieldCode="AU" term="%22Maeda+P%22">Maeda P</searchLink>; Lilly, Indianapolis.<br /><searchLink fieldCode="AU" term="%22Peterson+P%22">Peterson P</searchLink>; Lilly, Indianapolis.<br /><searchLink fieldCode="AU" term="%22Lin+BK%22">Lin BK</searchLink>; Lilly, Indianapolis.<br /><searchLink fieldCode="AU" term="%22Frimodt-Moller+B%22">Frimodt-Moller B</searchLink>; Lilly, Copenhagen.<br /><searchLink fieldCode="AU" term="%22Goldman+J%22">Goldman J</searchLink>; University of California, Los Angeles, Los Angeles.<br /><searchLink fieldCode="AU" term="%22Drilon+A%22">Drilon A</searchLink>; Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22LIBRETTO-432+Trial+Investigators%22">LIBRETTO-432 Trial Investigators</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220255562%22">The New England journal of medicine</searchLink> [N Engl J Med] 2026 May 31. <i>Date of Electronic Publication: </i>2026 May 31. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Massachusetts+Medical+Society%22">Massachusetts Medical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0255562 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1533-4406 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200284793%22">00284793 </searchLink><i>NLM ISO Abbreviation: </i>N Engl J Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42223087 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1056/NEJMoa2602628 Languages: – Code: eng Text: English Titles: – TitleFull: Selpercatinib in Early-Stage RET Fusion-Positive Non-Small-Cell Lung Cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wu YL – PersonEntity: Name: NameFull: Hochmair M – PersonEntity: Name: NameFull: Yang Y – PersonEntity: Name: NameFull: Yang XN – PersonEntity: Name: NameFull: Tsuboi M – PersonEntity: Name: NameFull: Paz-Ares L – PersonEntity: Name: NameFull: Yang JC – PersonEntity: Name: NameFull: Wu L – PersonEntity: Name: NameFull: Kim HR – PersonEntity: Name: NameFull: Rieke DT – PersonEntity: Name: NameFull: Johnson M – PersonEntity: Name: NameFull: Besse B – PersonEntity: Name: NameFull: Sharma N – PersonEntity: Name: NameFull: Maeda P – PersonEntity: Name: NameFull: Peterson P – PersonEntity: Name: NameFull: Lin BK – PersonEntity: Name: NameFull: Frimodt-Moller B – PersonEntity: Name: NameFull: Goldman J – PersonEntity: Name: NameFull: Drilon A IsPartOfRelationships: – BibEntity: Dates: – D: 31 M: 05 Text: 2026 May 31 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1533-4406 Titles: – TitleFull: The New England journal of medicine Type: main |
| ResultId | 1 |